Literature DB >> 10735278

Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis.

M B Graeber1, S Kösel, R Egensperger, R B Banati, U Müller, K Bise, P Hoff, H J Möller, K Fujisawa, P Mehraein.   

Abstract

In 1911, Alois Alzheimer published a detailed report (Zbl. ges. Neurol. Psych. 4: 356-385) on a peculiar case of the disease that had been named after him by Emil Kraepelin in 1910. Alzheimer describes a 56-year-old male patient (Johann F.) who suffered from presenile dementia and who was hospitalized in Kraepelin's clinic for more than 3 years. Post-mortem examination of the patient's brain revealed numerous amyloid plaques but no neurofibrillary tangles in the cerebral cortex, corresponding to a less common form of Alzheimer disease which may be referred to as 'plaque only'. We have identified well-preserved histological sections of this case and performed mutational screening of exon 17 of the amyloid precursor protein gene and genotyping for apolipoprotein E alleles. The patient was shown to be homozygous for apolipoprotein allele epsilon3 and lacked APP mutations at codons 692, 693, 713 and 717. This case is of historical importance as it may have convinced Kraepelin to name the disease after his co-worker, Alois Alzheimer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10735278     DOI: 10.1007/s100480050011

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  32 in total

Review 1.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

Review 2.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.

Authors:  Ashok N Hegde; Sudarshan C Upadhya
Journal:  Biochim Biophys Acta       Date:  2010-08-03

3.  Intrinsic functional component analysis via sparse representation on Alzheimer's disease neuroimaging initiative database.

Authors:  Xi Jiang; Xin Zhang; Dajiang Zhu
Journal:  Brain Connect       Date:  2014-07-31

Review 4.  Alzheimer 100--highlights in the history of Alzheimer research.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

Review 5.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

Review 6.  Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role?

Authors:  Parul Bali; Debomoy K Lahiri; Avijit Banik; Bimla Nehru; Akshay Anand
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 7.  G proteins, p60TRP, and neurodegenerative diseases.

Authors:  Klaus Heese
Journal:  Mol Neurobiol       Date:  2013-01-24       Impact factor: 5.590

Review 8.  Molecular and cellular pathophysiology of preclinical Alzheimer's disease.

Authors:  Elliott J Mufson; Milos D Ikonomovic; Scott E Counts; Sylvia E Perez; Michael Malek-Ahmadi; Stephen W Scheff; Stephen D Ginsberg
Journal:  Behav Brain Res       Date:  2016-05-13       Impact factor: 3.332

Review 9.  CD 4+ T cells in the pathobiology of neurodegenerative disorders.

Authors:  Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-05-12       Impact factor: 3.478

10.  Oskar Fischer and the study of dementia.

Authors:  Michel Goedert
Journal:  Brain       Date:  2008-10-24       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.